Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrarectal vs Intravenous Quinine for Childhood Cerebral Malaria
NCT00124267Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Sep 2003
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of quinine in cerebral malaria (CM), sponsored by Makerere University. Status: unknown.
02
Drugs
quinine
03
Conditions
cerebral malaria (CM)
Beyond the preview
Go deeper on NCT00124267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124267.